Skip to Content

Join the 'Breast Cancer - Palliative' group to help and get support from people like you.

Breast Cancer - Palliative News

Surviving Spouse Still Influenced By the Other

Posted 1 day 1 hour ago by Drugs.com

FRIDAY, Feb. 5, 2016 – The influence of a husband or wife on their spouse's quality of life remains strong even after death, a new study says. Couples who have been married a long time develop a high level of interdependence, and one partner's quality of life at death continues to influence the survivor, the University of Arizona researchers said. "If your partner has higher quality of life before they pass away, you're more likely to have higher quality of life even after they're gone. If he or she has lower quality of life before they pass away, you're then more likely to have lower quality of life," lead author Kyle Bourassa, a psychology doctoral student, said in a university news release. The researchers examined data from thousands of older couples in 18 European countries and Israel taking part in an ongoing study of health, aging and retirement. Specifically, the researchers ... Read more

Related support groups: Cancer, Colorectal Cancer, Breast Cancer - Palliative, History - Skin Cancer

Breast Cancer Survivors Vulnerable for Thyroid Tumors, and Vice Versa: Study

Posted 1 day 1 hour ago by Drugs.com

FRIDAY, Feb. 5, 2016 – Women who survive breast or thyroid cancer are linked to an increased risk for the other, according to a new analysis. University of Chicago researchers who reviewed 37 published studies found breast cancer survivors were 1.55 times more likely to develop thyroid cancer than women who hadn't had breast cancer. And, female thyroid cancer survivors were 1.18 times more likely to get breast cancer than women who hadn't had thyroid cancer, researchers said. "This is a real risk," said study lead author Dr. Raymon Grogan, director of the university's endocrine surgery research program. "People who have had one of these cancers need to be aware that they are at higher risk for developing the other cancer," he said. Thyroid cancer cases have nearly tripled in the United States over the past 30 years, and breast cancer is the most common cancer among women, according to ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Thyroid Tumor, Osteolytic Bone Metastases of Breast Cancer

Majority of Americans and Canadians Expects Cancer Cure in Their Lifetime

Posted 2 days 7 hours ago by Drugs.com

THURSDAY, Feb. 4, 2016 – A majority of American and Canadian adults believe a cure for cancer will be found in their lifetime, and that a cancer diagnosis is not a death sentence, according to a new Harris Poll. Nearly three out of five Americans and Canadians expect a cure for cancer in their lifetime. That belief is especially strong among those ages 18 to 34. Nearly three-quarters of young Americans and 69 percent of Canadians in that age group expect a cure in their lifetime. And, about two-thirds of Americans and Canadians don't think death is inevitable when someone is diagnosed with cancer, the poll found. However, Americans adults under 35 are more likely to believe that a cancer diagnosis is a death sentence than those 35 and older (39 percent vs. 29 percent). Americans whose lives have been affected by cancer are also more likely to view cancer as deadly compared to those who ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Stomach Cancer, Breast Cancer, Prevention, Head and Neck Cancer, Gastric Cancer, Breast Cancer - Palliative, Testicular Cancer, Solid Tumors, Urinary Tract Cancer

Health Tip: Getting Healthier After Cancer

Posted 9 days ago by Drugs.com

-- A recurrence of cancer and other chronic health conditions, such as weight or heart problems, are common concerns after cancer treatment. The American Society of Clinical Oncology recommends these lifestyle changes: Eat more nutritious foods. Stop using tobacco and restrict alcohol intake. Increase physical activity in safe and effective ways. Figure out healthy ways to manage stress. Read more

Related support groups: Cancer, Breast Cancer, Colorectal Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative

Smoking Lowers Breast Cancer Survival, Study Finds

Posted 11 days ago by Drugs.com

TUESDAY, Jan. 26, 2016 – Women diagnosed with breast cancer who continue to smoke cigarettes are less likely to survive than those who never smoked or those who quit, new research finds. The study suggests that it's never too late to quit smoking to help boost cancer survival. "Women who quit smoking at the time of their diagnosis do better, they have better outcomes than women who continue to smoke after the diagnosis," noted study leader Michael Passarelli, a cancer epidemiologist at the University of California, San Francisco. The smokers also had a higher risk of dying from respiratory cancers or heart disease and strokes, the research team found. The study was published online Jan. 25 in the Journal of Clinical Oncology. The researchers looked at the data from more than 20,000 women. The women were between the ages of 20 and 79, and nearly all were white. All had been diagnosed ... Read more

Related support groups: Smoking, Breast Cancer, Smoking Cessation, Breast Cancer, Prevention, Breast Cancer - Palliative

Families Say Hospice Better Than Hospital for Dying Cancer Patients

Posted 18 days ago by Drugs.com

TUESDAY, Jan. 19, 2016 – Families of patients dying of cancer felt their loved one had better care and quality of life when they died in a hospice rather than in a hospital's intensive care unit, a new study reveals. Relatives reported a better end-of-life experience more often when their loved one received hospice care for more than three days (59 percent) than those who received hospice care for three or fewer days (43 percent). Moreover, only 45 percent of families reported excellent care when the patient was admitted to a hospital intensive care unit (ICU) within 30 days of dying, the researchers found. "Our findings are a powerful argument for the importance of advance care planning," said lead researcher Dr. Alexi Wright, an associate professor of medicine at Harvard Medical School in Boston. How and where people die strongly shapes patients' dying experience and how family ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Brain Tumor, Melanoma, Skin Cancer, Endometrial Cancer, Bladder Cancer, Head and Neck Cancer, Gastric Cancer, Breast Cancer - Palliative

Doctors Choose Less Aggressive Care at End of Life, Studies Reveal

Posted 18 days ago by Drugs.com

TUESDAY, Jan. 19, 2016 – Doctors facing death are less likely to demand aggressive care that might squeeze out a bit more extra time of life, two new studies show. One study found that doctors facing the end of their lives are less likely than the general public to undergo surgery, be treated in an intensive care unit or die in a hospital. "It seems to confirm the idea that physicians understand the limits of modern medicine at the end of life," said lead author Joel Weissman. He is deputy director and chief scientific officer of the Center for Surgery and Public Health at Brigham and Women's Hospital in Boston. "When faced with that kind of decision, they choose to have more peaceful and less aggressive care at end of life," Weissman added. Those findings were backed up by the second study, which found that physicians and people with higher education are less likely to die in a ... Read more

Related support groups: Cancer, Breast Cancer - Palliative

Early Chemo Less Likely to Help Black Breast Cancer Patients: Study

Posted 12 Dec 2015 by Drugs.com

FRIDAY, Dec. 11, 2015 – Early chemotherapy is less likely to benefit black women with breast cancer than those in other racial and ethnic groups, a new study finds. Advanced breast cancer is more common among black, Hispanic and Asian women than it is in white women. As a result, black women often receive chemotherapy before surgery in an effort to improve their outcomes, the Yale University Cancer Center researchers said. But their study of 27,300 women with stage 1 to 3 breast cancer showed that early (neoadjuvant) chemotherapy was less effective in black patients than in other women. "Even when we controlled for the fact that minority women often present with more advanced-stage, higher-grade tumors, and more aggressive types of breast cancer overall, our team was surprised to find that black women did not respond as well to neoadjuvant chemotherapy compared to other racial groups," ... Read more

Related support groups: Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Femara, Lupron Depot, Breast Cancer, Metastatic, Anastrozole, Zoladex, Evista, Megace, Megestrol, Aromasin, Letrozole, Herceptin, Casodex, Breast Cancer - Adjuvant

Two Drugs Equal in Preventing Early Breast Cancer's Return: Study

Posted 11 Dec 2015 by Drugs.com

FRIDAY, Dec. 11, 2015 – Postmenopausal women who have an early, noninvasive form of breast cancer had similar recurrence rates of disease whether they took the drug tamoxifen or the aromatase inhibitor anastrozole after surgery, new research shows. However, the side effects of the two medications differed greatly, said study author Jack Cuzick, director of the Wolfson Institute of Preventive Medicine at Queen Mary University of London, England. His team looked at nearly 3,000 women, all past menopause, who had hormone-receptor positive ductal carcinoma in situ (DCIS) breast cancer and underwent surgery to excise it. With DCIS, the cells that line the milk ducts have changed but not spread into the surrounding breast tissue. Half the women were randomly assigned to take 1 milligram (mg) a day of anastrozole (Arimidex), while the other half took 20 mg a day of tamoxifen (Nolvadex). Each ... Read more

Related support groups: Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Femara, Lupron Depot, Breast Cancer, Metastatic, Anastrozole, Zoladex, Evista, Megace, Megestrol, Aromasin, Letrozole, Herceptin, Casodex, Breast Cancer - Adjuvant

Timing May Be Key to Success of Surgery, Chemo for Early Breast Cancer

Posted 10 Dec 2015 by Drugs.com

THURSDAY, Dec. 10, 2015 – The sooner early stage breast cancer patients have surgery following their diagnosis, and chemotherapy after their surgery, the better their chances of survival, two new studies find. In one study, researchers at Fox Chase Cancer Center in Philadelphia analyzed data from more than 94,500 American women aged 66 and older. All were diagnosed with breast cancer between 1992 and 2009. The team, led by Dr. Richard Bleicher, found a 9 percent increased risk of death from all causes for each 30-day delay in the time from diagnosis to surgery. The link between time to surgery and risk of death from all causes was only statistically significant for patients with earlier stages of cancer, the researchers noted. In the study, delays seemed to affect prognosis for patients with stage 1 and stage 2 cancers, but not for those with stage 3 cancers. The findings were similar ... Read more

Related support groups: Surgery, Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Femara, Lupron Depot, Breast Cancer, Metastatic, Anastrozole, Zoladex, Evista, Megace, Megestrol, Aromasin, Letrozole, Herceptin, Casodex

Depression May Be Tied to Lower Breast Cancer Survival

Posted 10 Dec 2015 by Drugs.com

THURSDAY, Dec. 10, 2015 – Breast cancer patients with depression may have a much higher risk of death than those without the mental illness, a new study suggests. "Low mood and depression are understandable reactions to a breast cancer diagnosis. Clinicians generally know to look out for this, but these findings emphasize the need to ask patients with cancer about their mood and for women to know it's OK to ask for help," Elizabeth Davies, of the division of health and social care research and cancer studies at King's College London, said in a school news release. "It is important women feel they can talk about these feelings and do not feel guilty about difficulty coping or depression, which can be a natural response to cancer diagnosis," she added. Although this study found a link between depression and breast cancer survival, it's important to note that the research can't prove ... Read more

Related support groups: Depression, Lexapro, Zoloft, Cymbalta, Effexor, Prozac, Celexa, Provera, Paxil, Citalopram, Depo-Provera, Pristiq, Sertraline, Major Depressive Disorder, Amitriptyline, Fluoxetine, Effexor XR, Venlafaxine, Breast Cancer, Savella

Lumpectomy Plus Radiation May Beat Mastectomy for Early Breast Cancer

Posted 10 Dec 2015 by Drugs.com

THURSDAY, Dec. 10, 2015 – Women with early stage breast cancer may survive longer if they opt for the less-extensive surgery called lumpectomy, followed by radiation, rather than a mastectomy, a new study suggests. "I think these results offer women important information to discuss with their doctors when making a treatment decision for early stage breast cancer," said lead researcher Sabine Seisling, of the Netherlands Comprehensive Cancer Organization, in Utrecht. Mastectomy removes the entire the breast, while lumpectomy involves removing only the tumor with some surrounding tissue. Some studies have suggested that women with early stage breast cancer have a better five-year survival rate after lumpectomy. The new study, which included 37,000 Dutch women, found that the advantage may also extend to the longer term. Of nearly 22,000 patients who underwent lumpectomy plus radiation, ... Read more

Related support groups: Surgery, Cancer, Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Femara, Lupron Depot, Zoladex, Anastrozole, Evista, Megace, Megestrol, Aromasin, Letrozole, Casodex, Breast Cancer - Adjuvant

Drugs May Protect the Heart During Chemotherapy

Posted 9 Dec 2015 by Drugs.com

WEDNESDAY, Dec. 9, 2015 – Two kinds of medications can prevent heart damage in breast cancer patients as they undergo chemotherapy, a new study suggests. Chemotherapy improves survival among women with early-stage breast cancer, but can dramatically increase their risk of heart failure, the researchers explained. This five-year study of 100 early-stage breast cancer patients in Canada found that two kinds of heart medicines – beta blockers and ACE inhibitors – seem to protect the heart during chemotherapy. "We think this is practice-changing. This will improve the safety of the cancer treatment that we provide," study co-investigator Edith Pituskin, an assistant professor in the Faculty of Nursing and Faculty of Medicine and Dentistry at the University of Alberta in Canada, said in a university news release. The heart medications not only protect the heart, but may also improve ... Read more

Related support groups: Lisinopril, Provera, Metoprolol, Depo-Provera, Atenolol, Breast Cancer, Propranolol, Lupron, Heart Failure, Bystolic, Congestive Heart Failure, Carvedilol, Tamoxifen, Medroxyprogesterone, Arimidex, Ramipril, Bisoprolol, Coreg, Femara, Enalapril

Experts Issue Guidelines on Caring for Breast Cancer Survivors

Posted 7 Dec 2015 by Drugs.com

MONDAY, Dec. 7, 2015 – Battling breast cancer is tough, but survivors need care, too. Now, two major groups in cancer care have issued guidelines on the type of follow-up these patients require. The protocols, released jointly by the American Cancer Society and the American Society of Clinical Oncology, are "much needed for the 3.1 million breast cancer survivors who are alive in the United States today," said one expert, Dr. Eleonora Teplinsky, a medical oncologist with North Shore-LIJ Cancer Institute in Lake Success, N.Y. "Survivorship is defined as living with, through and beyond cancer, and each of these phases comes with unique concerns and challenges," she said. According to the new guidelines, regular monitoring of patients for the return of any cancer is one key recommendation. This monitoring should include evaluation – such as a detailed cancer history and physical ... Read more

Related support groups: Breast Cancer, Tamoxifen, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Osteolytic Bone Metastases of Breast Cancer, Breast Cancer - Male, Tamosin, Emblon, Nolvadex, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen

Researchers Focus on Risk Factors for Leukemia After Breast Cancer Treatment

Posted 7 Dec 2015 by Drugs.com

MONDAY, Dec. 7, 2015 – Researchers say they're zeroing in on factors that may increase the risk of leukemia after breast cancer treatment. The findings are a step forward in determining ways to prevent this complication in breast cancer survivors. While the breast cancer treatments target malignant cells, they can also affect healthy cells and could increase the risk of leukemia later, the researchers said. The scientists looked at 88 breast cancer survivors with treatment-related leukemia and found that many had a personal and family history of cancer, suggesting a genetic susceptibility to cancer. Also, 20 percent of the women had an inherited gene mutation that increases the risk of breast cancer, according to the study published Dec. 7 in the journal Cancer. "The findings justify a long-term, follow-up study of women with and without inherited breast cancer gene mutations who are ... Read more

Related support groups: Provera, Depo-Provera, Breast Cancer, Lupron, Tamoxifen, Medroxyprogesterone, Arimidex, Leukemia, Femara, Lupron Depot, Breast Cancer, Metastatic, Zoladex, Anastrozole, Evista, Megace, Megestrol, Aromasin, Letrozole, Herceptin, Casodex

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

estradiol, testosterone, Premarin, tamoxifen, Estrace, ethinyl estradiol, fluorouracil, Zoladex, Megace, view more... megestrol, Estradiol Patch, Cenestin, Enjuvia, Depo-Testosterone, Testopel, Menest, Testopel Pellets, Android, methyltestosterone, goserelin, Progynova, Megace ES, conjugated estrogens, Delatestryl, esterified estrogens, Methitest, Testred, Adrucil, Thais, Tamoxifen Hexal, Estratab, Delatest, Testoderm, Everone, Virilon IM, Depotest, Testolin, Testro AQ, Testamone-100, Thaissept, Histerone, Testro-LA, Testro, FIRST-Testosterone MC, Halotestin, Premarin Intravenous, Meditest, Durathate 200, Andro-Cyp 100, Andro-Cyp 200, Depandro 100, Duratest, Andro LA 200, Genox, Virilon, Estinyl, Android-10, Android-25, Oreton Methyl, Soltamox, Teslac, fluoxymesterone, testolactone, Androxy, Nolvadex, Tamone, Emblon, Zumenon, Sandrena, Primogyn Depot, Oromone, Provames, Progynova TS, Valergen, Tamofen, Nolvadex D, Tamoxen, Tamosin, Systen